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also revealed information about numerous other medications, and provided unexpected 48 dietary insights that in turn improved our understanding of the molecular patterns on the 49 impact on the community microbial structure. These results suggest that untargeted 50 metabolomics data provide empirical evidence to correct records of non-model 51 organisms in captivity, although we also expect these methods will be appropriate for 52 experimental conditions typical in human studies. 53 1. Introduction: 71 The microbiome is accepted as a critical aspect of organismal health, with much 72 attention being focused on the gut microbiome. This environment is variable, in part 73 defined by an irregular flow of inputs, including diet and medications such as antibiotics, 74 that impact and shape the microbial community (1) (2) (3) (4) (5) (6) (7) . Common ways to examine this 75 variability are to profile microbial community structure and functional capacity, and less 76 frequently functional activity and output, including metabolite signatures. Correct 77 interpretation of these profiles relies on the detailed, relevant metadata that form the 78 foundation for all analyses and applications of the data. 79
A mismatch between collected metadata and variables of interest can result from 80 a multitude of reasons, with reporting errors and biases, omission of categories in the 81 metadata based on original study design, unexpected exposures, and poorly structured 82 or inconsistent descriptors amongst the most common. The approach of some large 83 human cohorts, such as the American Gut Project (8) , has been to capture an extensive 84 array of information using controlled vocabulary and values to maximize the likelihood of 85 having relevant metadata. However, cohorts that rely on self-reported information and 86 self-initiative to complete run the risk of obtaining erroneous, incomplete, and variable 87 amounts of metadata for each sample. Social pressures or fear of repercussions may 88 further prevent the disclosure of illicit or sensitive information such as drug use, sexually 89 transmitted diseases, poor hygiene or diet, etc. and temporal distance inevitably 90 complicates the recall of dietary, medication, and health-related events (9). For 91 example, metabolite analysis detected the presence of antibiotics in fecal samples from 92 individuals that reported not having taken antibiotics in the past 6 months or more (8) . 93 5 Furthermore, a central issue across microbiome studies is that it is very challenging to 94 capture additional participant information after a study has been completed, either due 95 to the self-reported nature, unresponsive subjects, or simply the passage of time. 96
We propose that metabolite-informed microbiome analyses, where the small-97 molecule composition of a sample, readily detected using a liquid chromatography -98 tandem mass spectrometry (LC-MS/MS) workflow, can be used to generate empirically 99 determined metadata assignments for compounds such as medications, including 100 antibiotics or painkillers, and personal care products, such as sunscreen. In particular, 101 the use of antibiotics in a clinical setting is common, impacting organisms from 102 livestock, domestic animals, captive wildlife, to humans of every age. Antibiotics have a 103 strong documented impact on the gut microbial community (1) (2) (3) (4) (5) , often resulting in large 104 decreases in alpha diversity. These changes in alpha diversity have the potential to alter 105 microbial community structure and the gut metabolome. Antibiotics have also been 106 shown to influence the gut microbial communities of members of a household where 107 one individual is taking antibiotics (10). The route of impact was, however, not clear, 108 leaving open the possibility of a shift in the microbiome that is microbially or chemically 109 mediated, possibly through transfer of the drug itself between individuals. 110 Animals in managed care, such as cheetahs (Acinonyx jubatus), have many 111 similarities to human patients in a clinical setting. Interventions are only attempted when 112 deemed medically necessary, and, based on individual health history, each animal has 113 a unique combination of housing location, diet, medication use, and environmental 114 exposure. Cheetahs in captivity suffer from higher rates of veno-occlusive disease and 115 gastrointestinal distress than their wild counterparts (11), leading to multiple treatment 116 6 interventions, such as changes in diet and medications. However, unlike human 117 subjects, zoo animals do not self-report information, and detailed records of food 118 consumption, medication use, health parameters, housing, and behavior are recorded 119 by keepers and trainers to capture these interventions. These detailed metadata and 120 controlled conditions provide an ideal setting for examining the complementarity of a 121 metabolome-informed approach to microbiome analyses. 122
Here, we present a workflow ( Figure 1 ) for generating study-specific 123 metabolome-informed metadata categories, using cheetahs as a case study, and 124 highlight the value of the approach for generating empirical metadata and reinterpreting 125 the data. Finally, we discuss broader applications of using empirical evidence to correct 126 sample categorization and records and provide concrete examples where this technique 127 is anticipated to have the greatest impact, suggesting areas where metabolomic data 128 should be routinely collected. 129 7 thereby assessing the chemistry of individuals as well as differences between 139 individuals or populations. Broad untargeted metabolomics is able to identify 140 compounds that corroborate or challenge metadata assignments and can thus be 141 inspected in a concerted fashion for accuracy based on individual study design ( Figure  142 1) and therefore provide valuable empirical evidence to enhance the accuracy of our 143 analyses. Combined, these data provide a window into the community structure as well 144
as the inputs that are entering the gut microbial environment, including host, diet, and 145 medication-related compounds. 146
Discovery of inconsistency between reported and detected MS data 147
Initial inspection of the metabolome and metagenome identified antibiotic use as 148 a main driver of differences between samples, as observed by principal coordinate 149 analysis (PCoA) (Figure 2a -b), with the first principal axis (PC1) explaining 32.37% of 150 the variance in the metabolome and 70.23% for the microbiome. The between sample 151 distances from PCoA clearly differentiated the majority of the fecal samples belonging to 152 the male cheetah Isoka, who was treated for gastritis with medication, including two 14-153 day courses of the antibiotic amoxicillin. Interestingly, a fraction of samples reported in 154 the metadata as 'no antibiotic use' cluster together with the 'antibiotic use' samples, 155
indicating a molecular as well as microbial similarity. 156
We traced the origin of these 'no antibiotic use' samples to one individual, the 157 male cheetah Okubi (Fig 2a-b , blue within the red oval) who did not receive any 158 medications during the sampling period. However, Isoka and Okubi are co-housed male 159 siblings, which presented a risk for misidentification of the source animal for fecal 160 samples, which would impact the findings directly. Therefore, medications were 161 individually orally administered and glitter was added to Isoka's diet (Rx antibiotic), in 162 order to verify which stool sample originated from which animal. Unlike captive rodents 163 and some domestic animals, cheetahs are not coprophagic, i.e. do not eat each other's 164 stool, limiting the potential routes of molecular sharing. Instead, we hypothesize that 165 grooming and other social interactions (13) could have led to direct medication 166 carryover. 167
We tested this hypothesis by examining whether any of the antibiotics Isoka 168 received were detected in the metabolomics data of the fecal samples from Okubi. 169
The hydrolyzed form of amoxicillin was detected by library identification in samples from 170 both Isoka (Rx antibiotic) and Okubi (no Rx) using the web-based global natural 171 products (GNPS) analysis platform (https://gnps.ucsd.edu) (14) which provides 172
Metabolomics Standards Initiative level II or III identifications (15). Moreover, this 173 antibiotic was not detected in any samples from the other cheetahs. During the month 174 long time course, Isoka was on prescription antibiotics for 24 days (out of 29 total 175 samples) and the amoxicillin derivative was detected in 23 samples from Isoka and 176 intermittently in 10 samples from Okubi, which also group together based on PCoA 177 (squares, Figure 2f ). 178
Using a multi-omic microbe-metabolite co-occurrence analysis we observed a 179 strong trend with antibiotic use across both datasets, with highly correlated microbes 180 and metabolites also co-occurring ( Figure 2b ). Untargeted metabolomics identified 181 members of the molecular family of plant products, soyasaponins, and their degradation 182 products (such as that in Figure 2c ) in stool of cheetahs consuming Nebraska Brand 183 Special Beef Feline Diet. These ingredients, not initially part of the metadata collection, 184 9 were confirmed by the manufacturer ingredient list of the dietary product 185 (http://www.nebraskabrand.com/docs/beefsheet2019pdf.pdf). 186
One class of correlated molecules includes the soyasaponins, where we identified both 187 precursor (soyasaponin I) and metabolite (soyasapogenol C). Previously, microbial 188 fermentation has been implicated with the conversion of these compounds to their 189 aglycone metabolites (Hu et al., 2004) . These results support our findings, as the 190 microbially-derived metabolite soyasapogenol C is correlated with no antibiotic use, 191 while the precursor is correlated with antibiotic use (Figure 2b ). In addition to these 192 observed changes in the metabolome following antibiotic exposure, the presence of 193 soyasapogenol C has a high co-occurrence probability with Firmicutes and 194 Proteobacteria, with G000425865 among the most differential microbes in the analysis 195 (Table S1) show differential metabolism of soy carbohydrates and mirror the medication schedule 201 for Isoka (Rx antibiotic, Figure 2f ) and this empirical evidence supports restructuring of 202 the metadata from antibiotic reported to detected. Antibiotic annotation based on 203 metadata revealed a correlation between antibiotic detection and microbial food 204 metabolism. We observed the breakdown of soyasaponin across animals ( Figure 2d , 205 min max range of other animals shaded gray) and a stark absence of the aglycone, 206 10 soyasapogenol C, when antibiotics were empirically detected in the feces by MS ( Figure  207 2d,e,f). 208 
Metabolome-informed metabolome analysis 224
Antibiotics imparted a strong signature to the differences between samples, both 225 in terms of the medication itself, metabolism of soy carbohydrates, as discussed above, 226 as well as changes in host and host-microbial metabolism. The hydrolyzed amoxicillin 227 detected by MS was positively correlated with antibiotic use and highly ranked ( Figure  228 3a), based on a differential abundance analysis. Furthermore, antibiotic use had a 229 11 profound influence on bile acid metabolism. Conjugated bile acids correlate with 230 antibiotic use (Figure 3b ), whereas primary bile acids are negatively correlated with 231 antibiotic use. The log ratio of conjugated (primary and secondary) bile acids divided by 232 primary bile acids is elevated for Isoka and Okubi (Figure 3d ) and the difference 233 between the MS-metadata informed categories can be clearly seen in Figure 3c , left 234 and right, respectively. In both cases the difference between antibiotic use and not is 235 statistically significant (Welch's t-test; p value: 4.5e-49 (MS_reported) and 1.3e-31 236 (MS_detected). In particular several outliers in no antibiotic use reported are removed 237 when comparing the antibiotic detected categories. 238 Furthermore, application of this informed metadata variable to the metabolite 239 data still showed that the main driver in separation of cheetah fecal material was 240 antibiotic detection, with PC1 representing 32.37% of the variance in the dataset and 241 effectively separating Isoka and some of Okubi's samples from the remaining animals 242 ( Figure S1a ). Based on a PERMANOVA analysis of the weighted unifrac distance 243 matrix, categorization based on metabolite data resulted in a larger effect size (F-244 statistic for the two different metadata categories: antibiotic use (reported) = 28.2433 245 compared with antibiotic_presence_WD (detected) = 47.4572.) 246
Thus, one loop of application of the MS-informed metadata has been completed, 247 applying a new categorization of antibiotic use which reflects the mass spectral data. 248
Recategorization will impact data interpretation: removal of these samples from further 249 analysis reduces the chances of data misinterpretation due to the outliers originally 250 present. Furthermore, the same changes applied based on the MS-informed metadata 251
can be applied to any additional paired dataset. 252
Metabolome-informed metagenome analysis 253
The metagenome results also have a larger effect size for the metadata assigned 254 due to metabolite analysis (detected) compared with the original metadata (reported) 255 (PERMANOVA F-statistic calculated from the weighted unifrac distance matrix: 41.7599 256 for antibiotic_use (reported) compared with 75.9906 for antibiotic_presence_WD 257 (detected)) ( Figure 1b vs. Figure S1b) . The same trend held true for the unweighted 258 distance matrix ( Figure S2 Metabolome data-informed grouping, which was empirically validated, could be 297 used to stratify individuals, to identify criteria of interest, or to flag samples for exclusion 298 14 from further analysis. In this case, removal of samples from animals exposed to 299 antibiotics, Isoka and Okubi, and recomputation of the PCoA of metabolite data 300 revealed new trends (Figure 4c ). Exclusion of samples from Isoka and Okubi (Figure 4c ) 301 resulted in no per individual differences along PC1, however, there was a clear 302 separation of Johari (severe disease) and Amara (mild disease), from the remaining 303 healthy individuals along PC2, representing 22.52% of the variance. 304
We hypothesized that the strong signature from denamarin metabolites was 305 driving this difference in beta diversity and a further iteration of MS-informed analysis 306 was performed (Figure 1 ). The untargeted metabolomics feature table was filtered to 307 remove metabolite signatures for S-adenosyl methionine, as well as its breakdown 308 products, from the metabolite feature table (red in Figure 4a ). Analysis of the modified 309 set of features resulted in decreased separation of metabolite signatures from the 310 cheetahs Johari and Amara (Figure 4d ). We observed that along PC1, Johari, with 311 severe CLNS (data points displayed as green stars), was most disparate, while Amara, 312 with a diagnosed mild case (red squares), was not clearly distinguishable from the 313 healthy individuals, as seen in the metagenomic analysis as well. 314
Although the sample size is small, as is common with studies in captive wildlife, a 315 comparison of clinical data for Amara and Johari (Table S2) 3/20/18, just after sampling for this study, her levels were within healthy limits at 61 and 323 13 μ mol/L for ALT and AST, respectively. Peripheral bile acid levels were similarly 324 elevated for Johari as well as Amara in 2017 but within normal limits for Amara in 2018 325 (Table S2 ). The metabolome profile and presence of Amara's samples with other 326 healthy individuals is supported by the lower ALT, AST and bile acid levels measured 327 shortly after the sampling time period, indicating a possible recovery back to a more 328 healthy phenotype within this case study. 329
Discussion 330
There are confounders in clinical datasets that cannot be predicted based on 331 available information. Broad untargeted metabolomics gives insights into specific 332 molecules that can reveal unexpected factors that, if not understood, might lead to 333 misinterpretation of the data. In this study, we observed an individual reported not to 334 have been administered antibiotics during the study period but detected antibiotics in 335 their stool. Taking this information into account to generate an MS-informed metadata 336 category for antibiotic use allowed a more informative analysis of the samples. Similarly, 337 upon observation of denamarin metabolites, their signatures could be removed as a 338 result of treatment for liver disease, rather than attributing them as drivers of the 339
condition. 340
This case study in captive cheetahs illustrates something unique: if the cohort 341 were made up of humans living in a household together, then one individual would 342 'correctly' have self-reported antibiotic use, while the other would have also 'correctly' 343 16 reported not taking antibiotics (or have been monitored by a clinician as not taking 344 antibiotics), but these reports do not accurately reflect antibiotic exposure. MS-informed 345 analyses driven by empirically detected information can therefore reveal elusive 346 information and go beyond even the best (and most intrusive) clinical study. The use of 347 antibiotics by one human household member has been shown to impact the gut 348 microbiota of other members of the same household (10). Although the direct 349 mechanisms of microbiome alteration were not clear in this study, it is reasonable to 350 hypothesize that antibiotic exposure through physical contact with one another, or via 351 household surfaces, may contribute to the carryover of the medications and ultimately 352 impact the gut microbiome. This further raises the question of privacy concerns and 353 whether information from spouses or household members (perhaps even including pets) 354 would also need to be collected for correct interpretation of clinical trials, or if categories 355 such as 'has anyone in your household taken antibiotics within the last week?' would be 356 appropriate to include across all studies. The carryover of substances, such as personal 357 care products, medication, and food-derived molecules, from an individual to household 358 surfaces has been well documented (16, 17) , however, the ability to transfer antibiotics 359 or indeed other medications from one person to another still remains to be verified. 360
Identification of confounders that cannot be taken into account initially is a reality 361 of clinical data for captive animals, as we have shown, and is likely also the case for 362 human studies. In the current study, to address the signatures of liver disease, the 363 observation of unexpected antibiotics across numerous samples was very valuable; 364 otherwise Okubi's samples (no Rx) that contained antibiotics would continue to be 365 included as 'healthy', which is true with respect to liver disease, but there is a 366 substantial and clear shift in this cheetah's microbiome due to antibiotic exposure. As 367 antibiotics are a stronger driver of difference than the disease state, it was appropriate 368 in this case to remove the samples from both animals from the analysis, as they would 369 otherwise be classified as 'healthy' because neither suffers from CLNS. 370
Metabolomics generates a verifiable readout that allows us to reinterpret the 371 study results in the context of the data or information that were actually collected and 372 can be done as an iterative process. Regardless of the origin of such observations, 373 whether it is metadata omission, misreporting, errors in sample collection, or other 374 causes, the fact remains that something is detected where it was not expected. The 375 power of using metabolomic data to reinterpret metadata categorization, impacting all 376 facets of gut microbiome data interpretation, has a critical place in microbiome analyses 377 going forward and virtually any study with samples amenable to MS data collection 378 could benefit from this approach. EtOH, to remove spurious fecal material. Samples were dried down overnight using a 429 Labconco CentriVac and either placed at -80 °C for storage, or immediately processed 430 as follows. A clean spatula and tweezers were used to transfer 50-100 mg of dried stool 431 into a new, labeled tube. Exact weights were recorded and a 10-fold volume of cold 432 50% MeOH in water was added to each tube (ex: 50 mg (stool) + 500 µL (50% MeOH)) 433 (LC-MS grade solvents, Fisher Chemical). The samples were homogenized for 5 434 minutes at 25 Hz on a tissue homogenizer (QIAGEN TissueLyzer II, Hilden, Germany), 435
and subsequently placed at -20 °C for 15 minutes for methanol extraction. The samples 436 were then centrifuged at max speed (14000 x g) for 15 minutes (Eppendorf Centrifuge 437 5418; USA). Without disrupting the pellet, 300 µL of the supernatant was transferred 438 into a 96-deep well plate. Samples were sealed and stored at -80 °C. 439 Metabolomics data acquisition and processing 440 Data were collected using a modification of the data dependent acquisition 441 method outlined in (18). Briefly, extracts were dried down, resuspended in 50% 442
MeOH:50% Water (Optima LC-MS grade; Fisher Scientific, Fair Lawn, NJ, USA). 443
Untargeted metabolomics was carried out using an ultra-high-performance liquid 444 chromatography system (UltiMate 3000, Thermo Scientific, Waltham, MA) coupled to a 445
Maxis Q-TOF (Bruker Daltonics, Bremen, Germany) mass spectrometer with a Kinetex 446 21 C18 column (Phenomenex Torrance, CA, USA). A linear gradient was applied: 0-0.5 447 min isocratic at 5% B, 0.5-8.5 min 100% B, 8.5-11 min isocratic at 100% B, 11-11.5 min 448 5% B, 11.5-12 min 5% B; where mobile phase A is water with 0.1% formic acid (v/v) Feature based molecular networking was performed and library IDs were generated 479 using GNPS (14) . 480
The quant table, SIRIUS export, and library identifications from feature based 481 molecular networking were used as inputs for the Qiime2 plugin Qemistree 482 (https://github.com/biocore/q2-qemistree), to perform hierarchical ordering of the 483 untargeted mass spectrometry data. The resultant Qemistree-based feature table can 484 be linked to the original feature number from feature finding (which also links to the 485 GNPS Library IDs) and presents fingerprints that act to merge spectra assigned the 486 same identity. Qemistree also generates a fingerprint-based tree, allowing for tree-487 based approaches such as UniFrac (19, 20 batch and not the other as frequently occurs due to instrument performance changes 495 during sample processing. Parameters such as gap filling and feature finding parameter 496 settings can further compound these issues. Therefore, weighted UniFrac is used for all 497 comparisons between mass spectral data which were processed using the QIIME 2 498 plugin q2-qemistree. 499 QIIME 2 (21) was used within a jupyter notebook environment for Principal 500
Coordinates Analysis. Differential abundance analysis was performed using Calour (or 501 replace with Songbird) (22). 502
Sample preparation and sequencing data generation 503 Shallow shotgun sequencing was performed as previously described (23) . In brief, DNA 504 extraction was performed using the Qiagen PowerSoil DNA extraction kit following the 505 Earth Microbiome Project (EMP) standard protocol (24). The Qubit™ dsDNA HS Assay 506 (ThermoFisher Scientific) was used to determine concentration and libraries were 507 prepared from 1 ng of input DNA in a miniaturized Kapa HyperPlus protocol. Libraries 508 were quantified using the Kapa Illumina Library Quantification Kit, pooled and size 509 selected (300-800 bp) using the Sage Science PippinHT. The pooled library was 510 sequenced as a paired-end 150-cycle run on an Illumina HiSeq 4000 mode at the 511 UCSD IGM Genomics Center.Demultiplexed sequences were trimmed and quality 512 filtered using Atropos v 1.1.5, a fork of Cutadapt (25). 513 24 Sequence data processing 514 Significant host contamination was expected from the horse, beef, and rabbit-based diet 515 of the cheetahs, as well as host DNA present in the samples. Therefore we identified 516 reads in the quality-filtered reads using Bowtie 2 v2.3.0 (26) Host-filtered reads were mapped to the 10,575 genomes selected for phylogenetic 525 reconstruction in the Web of Life project (https://biocore.github.io/wol/data/genomes/) 526 using Bowtie 2 within the alignment pipeline SHOGUN (12) using standard parameters. 527
Bowtie 2 mappings were normalized to distribute reads to individual genomes and the 528 resulting output matrix was filtered to remove reads present at less than 0.01% relative 529 abundance per sample. This filtered matrix was used for weighted UniFrac (19) ߚ represents the intercept of the multinomial regression. 549
550
The same regression formula was used to learn the differentials for the metabolites. 551
Differentials were visualized in rank plots using Qurro https://github.com/biocore/qurro, 553 while microbe-metabolite co-occurrence probabilities were computed using mmvec 554 https://github.com/biocore/mmvec. These co-occurrence probabilities represent the 555 probability of observing a metabolite given the microbe is observed. These conditional 556 probabilities are estimated through a low-rank approximation with 3 principal axes. 557 26 Data and Code Availability 558 All data in this study is publically available. Raw and processed shotgun sequencing 559 data is available in Qiita (31) study 11872 560 (https://qiita.ucsd.edu/study/description/11872) and GNPS (14) Table S1 . Top 20 species ranked based on co-occurrence probability with the 590 metabolite soyasaponin I. 591 Table S2 . Additional clinical measurements for diseased cheetahs Johari and Amara. 592 
